Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)Simon J. Crabb, Robert J. Jones, Ellice Marwood et al.|Journal of Clinical Oncology|2020Cited by 82